A detailed history of New Edge Advisors, LLC transactions in Illumina, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 2,274 shares of ILMN stock, worth $318,678. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,274
Previous 431 427.61%
Holding current value
$318,678
Previous $44,000 572.73%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$105.28 - $135.9 $194,031 - $250,463
1,843 Added 427.61%
2,274 $296,000
Q2 2024

Aug 15, 2024

SELL
$101.05 - $133.57 $50,019 - $66,117
-495 Reduced 53.46%
431 $44,000
Q1 2024

May 14, 2024

SELL
$127.73 - $147.2 $332,608 - $383,308
-2,604 Reduced 73.77%
926 $127,000
Q4 2023

Feb 13, 2024

BUY
$92.79 - $142.53 $154,031 - $236,599
1,660 Added 88.77%
3,530 $491,000
Q3 2023

Nov 14, 2023

BUY
$128.91 - $192.44 $103,901 - $155,106
806 Added 75.75%
1,870 $256,000
Q2 2023

Aug 14, 2023

BUY
$183.43 - $232.67 $12,289 - $15,588
67 Added 6.72%
1,064 $199,000
Q1 2023

May 12, 2023

SELL
$193.75 - $232.55 $139,693 - $167,668
-721 Reduced 41.97%
997 $231,000
Q4 2022

Feb 14, 2023

BUY
$187.24 - $242.74 $321,678 - $417,027
1,718 New
1,718 $347,000
Q4 2019

Jan 31, 2020

SELL
$288.29 - $335.49 $539,390 - $627,701
-1,871 Closed
0 $0
Q3 2019

Nov 06, 2019

SELL
$266.84 - $378.23 $36,823 - $52,195
-138 Reduced 6.87%
1,871 $569,000
Q2 2019

Aug 05, 2019

BUY
$300.59 - $368.15 $109,414 - $134,006
364 Added 22.13%
2,009 $740,000
Q1 2019

May 14, 2019

SELL
$272.57 - $321.18 $17.6 Million - $20.7 Million
-64,471 Reduced 97.51%
1,645 $511,000
Q1 2019

May 09, 2019

BUY
$272.57 - $321.18 $17.5 Million - $20.6 Million
64,224 Added 3394.5%
66,116 $79,000
Q4 2018

Jan 29, 2019

BUY
$272.46 - $366.54 $26,701 - $35,920
98 Added 5.46%
1,892 $567,000
Q3 2018

Oct 29, 2018

BUY
$279.04 - $367.06 $500,597 - $658,505
1,794 New
1,794 $659,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.